Xiamen, China

Zuxing Weng

USPTO Granted Patents = 2 


 

Average Co-Inventor Count = 7.5

ph-index = 1


Company Filing History:


Years Active: 2018-2023

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Zuxing Weng: Innovator in Hepatitis B Detection

Introduction

Zuxing Weng is a notable inventor based in Xiamen, China. He has made significant contributions to the field of medical diagnostics, particularly in the detection of hepatitis B. With a total of two patents to his name, Weng's work focuses on innovative methods for monitoring and controlling chronic hepatitis B.

Latest Patents

Weng's latest patents include a kit and method for quantitative detection of HBsAg. This kit is designed for the quantitative detection of HBsAg in samples, utilizing a first antibody that specifically binds to HBsAg. The reagent composition in the kit includes tris(2-carboxyethyl)phosphine hydrochloride (TCEP) and urea. Another significant patent is the anti-HBc quantitative detection method, which is instrumental in monitoring disease progression in chronic hepatitis B patients. This method allows for the quantitative detection of antibodies against hepatitis B core protein (Anti-HBc), aiding in predicting therapeutic effects and guiding treatment decisions for patients undergoing therapy.

Career Highlights

Weng has worked with esteemed institutions such as Xiamen University and Xiamen Innodx Biotech Co., Ltd. His experience in these organizations has contributed to his expertise in the field of hepatitis B diagnostics.

Collaborations

Weng has collaborated with notable colleagues, including Liuwei Song and Feihai Xu. These partnerships have further enhanced his research and development efforts in medical diagnostics.

Conclusion

Zuxing Weng's innovative work in hepatitis B detection showcases his commitment to improving patient outcomes through advanced diagnostic methods. His contributions are vital in the ongoing fight against chronic hepatitis B.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…